Nuvation Bio Inc.
NUVB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,873 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7,078 | $0 | $0 | $0 |
| Gross Profit | $795 | $0 | $0 | $0 |
| % Margin | 10.1% | – | – | – |
| R&D Expenses | $524,189 | $71,289 | $87,815 | $69,037 |
| G&A Expenses | $66,733 | $28,533 | $31,919 | $24,281 |
| SG&A Expenses | $69,233 | $28,533 | $31,919 | $24,281 |
| Sales & Mktg Exp. | $2,500 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $593,422 | $99,822 | $119,734 | $93,318 |
| Operating Income | -$592,627 | -$99,822 | -$119,734 | -$93,318 |
| % Margin | -7,527.3% | – | – | – |
| Other Income/Exp. Net | $24,688 | $24,020 | $15,535 | $6,470 |
| Pre-Tax Income | -$567,939 | -$75,802 | -$104,199 | -$86,848 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$567,939 | -$75,802 | -$104,199 | -$86,848 |
| % Margin | -7,213.8% | – | – | – |
| EPS | -2.11 | -0.35 | -0.48 | -0.44 |
| % Growth | -502.9% | 27.1% | -9.1% | – |
| EPS Diluted | -2.11 | -0.35 | -0.48 | -0.44 |
| Weighted Avg Shares Out | 268,772 | 218,880 | 216,721 | 197,887 |
| Weighted Avg Shares Out Dil | 268,772 | 218,880 | 216,721 | 197,887 |
| Supplemental Information | – | – | – | – |
| Interest Income | $27,062 | $24,611 | $7,448 | $2,963 |
| Interest Expense | $341 | $0 | $0 | $0 |
| Depreciation & Amortization | $683 | $222 | $199 | $184 |
| EBITDA | -$566,915 | -$75,580 | -$119,535 | -$93,134 |
| % Margin | -7,200.7% | – | – | – |